Tag: mirvetuximab soravtansine

Medical illustration showing targeted cancer therapy mechanism
Clinical UpdatesPractice

NHS Approves First New Ovarian Cancer Drug in 20 Years for Resistant Disease

NHS approves mirvetuximab soravtansine, the first new ovarian cancer treatment in over 20 years for women with platinum-resistant disease. The…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →